¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ MCE 2018 & 59Â÷ Ãß°èÇмú´ëȸ : 2018-11-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ MCE 2018 & 59Â÷ Ãß°èÇмú´ëȸ : 2018-11-03
±³À°ÀÏÀÚ : 2018-11-03
±³À°Àå¼Ò : ±×·£µå¿öÄ¿Èú ¼­¿ï Vista Hall ¿Ü  
±³À°ÁÖÁ¦ : LMCE 2018 & 59Â÷ Ãß°èÇмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ
´ã´çÀÚ : ±èÈñ¼ø
¿¬¶ôó : 02-795-9914  
À̸ÞÀÏ : kscp3@kams.or.kr      
±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú      
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 12 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 250,000¿ø      
ºñ°í Á¤È¸¿ø-10¸¸¿ø/ÁØȸ¿ø-8¸¸¿ø/ºñȸ¿ø-25¸¸¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 03ÀÏ Vista Hall 1(B2) 08:00~08:40 KS03: Bioactive lipids in laboratory medicine  Yutaka Yatomi(Graduate School of Medicine The University of Tokyo Japan) 
±³À°½Ã°£ 11¿ù 03ÀÏ Vista Hall 1(B2) 09:00~09:40 SY14: CLSI document QMS19-Customer focus in a quality management system  Carl D. Mottram(Division of Pulmonary and Critical Care Medicine Mayo Clinic College of Medicine USA) 
±³À°½Ã°£ 11¿ù 03ÀÏ Vista Hall 1(B2) 09:40~10:20 SY14: CLSI document GP45-Studies to evaluate patient outcomes  James H. Nichols(Vanderbilt University School of Medicine USA) 
±³À°½Ã°£ 11¿ù 03ÀÏ Vista Hall 1(B2) 10:20~10:40 SY14: Developing and managing a medical laboratory (test) utilization management program  Sollip Kim(Ilsan Paik Hospital Inje University Korea) 
±³À°½Ã°£ 11¿ù 03ÀÏ Walker Hall 1 (1F) 09:00~09:30 SY15: Critical levels of serum 25-Hydroxyvitamin D for metabolic bone disease  Howard Morris(University of South Australia Australia) 
±³À°½Ã°£ 11¿ù 03ÀÏ Walker Hall 1 (1F) 09:30~10:00 SY15: Cannabinoids in California-approach to assessing driving under the influence  Robert L. Fitzgerald(University of California-San Diego USA) 
±³À°½Ã°£ 11¿ù 03ÀÏ Walker Hall 1 (1F) 10:00~10:20 SY15: Optiumu utilization of automated urine microscopy  Jeong-Ho Kim(Yonsei University College of Medicine Korea) 
±³À°½Ã°£ 11¿ù 03ÀÏ Walker Hall 1 (1F) 10:20~10:40 SY15: The significance of chitotriosidase determination in the diagnosis of inborn errors of metabolism  Yoon Shin-Podskarbi(Ludwig Maximilian University of Munich Germany) 
±³À°½Ã°£ 11¿ù 03ÀÏ Walker Hall 2 (1F) 09:00~09:30 SY16: Flow cytometry for acute leukemia diagnosis and classification  Chan-Jeoung Park(University of Ulsan College of Medicine Korea) 
±³À°½Ã°£ 11¿ù 03ÀÏ Walker Hall 2 (1F) 09:30~10:00 SY16: Clot wave form analysis, laboratory monitoring of bleeding in hemophilia  Midori Shima(Department of Pediatrics Nara Medical University Japan) 
±³À°½Ã°£ 11¿ù 03ÀÏ Walker Hall 2 (1F) 10:00~10:40 SY16: Update on the pathogenesis and laboratory diagnosis of thromboticthrombocytopenic purpura  Ross I. Baker(Murdoch University Australia) 
±³À°½Ã°£ 11¿ù 03ÀÏ Vista Hall 1(B2) 11:00~12:00 PL03: The fight against antimicrobial resistance: Are we doing right?  Jesús Rodríguez Baño(University of Sevilla Spain) 
±³À°½Ã°£ 11¿ù 03ÀÏ Vista Hall 1(B2) 13:00~13:40 KS04: Integrative microbiology & immunology-MPE (Molecular Pathological Epidemiology)  Shuji Ogino(Harvard Medical School USA) 
±³À°½Ã°£ 11¿ù 03ÀÏ Vista Hall 1(B2) 14:00~14:30 SY18: The coming era of precision medicine in infectious diseases  Jesús Rodríguez Baño(University of Sevilla Spain) 
±³À°½Ã°£ 11¿ù 03ÀÏ Vista Hall 1(B2) 14:30~15:00 SY18: Next generation sequencing in routine clinical microbiology  John Rossen(University of Groningen The Netherlands) 
±³À°½Ã°£ 11¿ù 03ÀÏ Vista Hall 1(B2) 15:00~15:30 SY18: Multiplex identification of major sepsis-Causing pathogens from the plasma of infected blood  Yeun-Jun Chung(The Catholic University of Korea Korea) 
±³À°½Ã°£ 11¿ù 03ÀÏ Walker Hall 1 (1F) 14:00~14:25 SY19: Chronic renal failure biomarker  Graham Jones(St Vincent¡¯s Pathology in Sydney Australia) 
±³À°½Ã°£ 11¿ù 03ÀÏ Walker Hall 1 (1F) 14:25~14:50 SY19: Biomarkers of diabetes  Philippe Gillery(Secteur Biochimie Pôle de Biologie Médicale et Pathologie France) 
±³À°½Ã°£ 11¿ù 03ÀÏ Walker Hall 1 (1F) 14:50~15:15 SY19: Guideline for protein electrophoresis tests for patient care  Helen Martin(Department of Biochemistry Healthscope Pathology Australia) 
±³À°½Ã°£ 11¿ù 03ÀÏ Walker Hall 1 (1F) 15:15~15:40 SY19: Next generation sequencing-based gene panel and exome testing  Chang-Seok Ki(Green Cross Genome Korea) 
±³À°½Ã°£ 11¿ù 03ÀÏ Walker Hall 2 (1F) 14:00~14:30 SY20: Transfusion practitioner  Rachel Moss(Great Ormond Street Hospital for Children NHS Foundation Trust UK) 
±³À°½Ã°£ 11¿ù 03ÀÏ Walker Hall 2 (1F) 14:30~15:00 SY20: Support of Blood Banks for surgery  David Roxby(Flinders Medical Centre Australia) 
±³À°½Ã°£ 11¿ù 03ÀÏ Walker Hall 2 (1F) 15:00~15:30 SY20: A consultant for clinicians  Sejong Chun(Chonnam National University Medical School Korea) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ MCE 2018 & 59Â÷ Ãß°èÇмú´ëȸ : 2018-11-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °³¿øÀǸ¦ À§ÇÑ ±¹¸³¾Ï¼¾ÅÍ ¿¬¼ö°­ÁÂ(2Â÷) : 2018-11-03
´ÙÀ½±Û ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ The 20th International Society of Addiction Medicine Annual Meeting 2018(ISAM Busan 2018) : 2018-11-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21060 ¿ï»ê ´ëÇÑ»êºÎÀΰúÀÇ»çȸ ¿ï»êÁöȸ ¿¬¼ö±³À°(¿ù°æÅë, µ¥³ë¼ö¹ä Áß´Ü ÈÄ ¹Ýµ¿°ñÀýÀÇ ¿¹¹æ) : 2024-07-04 0 12 2024-06-18
21059 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(3ÀÏÂ÷) : 2024-07-03 0 2 2024-06-18
21058 °æ±â 2024³â ÆòÅýÃÀÇ»çȸ ÇÏ°èÇмú´ëȸ : 2024-07-02 0 15 2024-06-18
21057 ¼­¿ï ¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(2ÀÏÂ÷) : 2024-07-02 0 8 2024-06-18
21056 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 3 2024-06-18
21055 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(1ÀÏÂ÷) : 2024-07-01 0 4 2024-06-18
21054 ÃæºÏ ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Understanding Current Community Mental Health and Emotional Disorders in ASD : 2024-07-01 0 10 2024-06-18
21053 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ °³¿øÀÇ ½ÉÆ÷Áö¾ö : 2024-06-30 0 18 2024-06-18
21052 °æ±â ´ëÇÑÁ¤ÇüÅëÁõÀÇÇÐȸ - Á¦2ȸ CHAMS °³¿øÀÇ ½ÉÆ÷Áö¾ö : 2024-06-30 0 15 2024-06-18
21051 ¼­¿ï 2024³â ´ëÇÑ°¡Á¤ÀÇÇÐȸ ¼­¿ïÁöȸ Çϰ迬¼ö°­Á : 2024-06-30 0 18 2024-06-18
21050 ºÎ»ê 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2024-06-30 0 17 2024-06-18
21049 ¼­¿ï Á¦26Â÷ ´ëÇѾƵ¿º´¿øÇùȸ Ãá°èÇмú´ëȸ : 2024-06-30 0 13 2024-06-18
21048 Ãæ³² 2024 ÀÌ°úÇÐ ¿¬±¸¼¼¹Ì³ª : 2024-06-29 0 6 2024-06-18
21047 ¼­¿ï ´ëÇѽÉÀåÈ£ÈíÀçÈ°ÀÇÇÐȸ Á¦14ȸ Çмú´ëȸ : 2024-06-29 0 12 2024-06-18
21046 ÀÎõ Á¦13Â÷ ÀÎõ½Ã³»°úÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-29 0 8 2024-06-18
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷